Bayer, Sun Pharma sign marketing and distribution agreement for second brand of Finerenone in India
Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa
Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa
The three-day event in Bengaluru was conducted in collaboration with the Karnataka Ophthalmology Society (KOS) and the Bangalore Ophthalmology Society (BOS)
Approval based on a separate phase III trial among Chinese patients reinforcing mepolizumab’s efficacy and safety data
Microdosing has emerged as a key trend in the pharmaceutical and nutritional markets
Inducts advanced AI-Powered 24x7 remote patient monitoring system
The latest upgraded Tele Clinic is Artificial Intelligence (AI) - driven to provide healthcare facilities in far flung areas of the region, where such facilities are either not available or inadequately available
The Aptivate Champion Run witnessed an enthusiastic participation of over 4,000 Mumbaikars
PharmaLogic will assist ARTBIO with radiochemistry and supply of the finished radiopharmaceutical product for future Phase I and II clinical trials of AB001 from their facility in New York
India’s First Integrated Ayush Wellness Centre to come up in Guwahati, foundation stone laid
Subscribe To Our Newsletter & Stay Updated